Triethylamine → (R)-3-[3-(3-chloro-phenyl)-[1,2,4]oxadiazol-5-yl]-butyric acid methyl ester

HRID 732063ノート

反応式

HRID 732063 の反応式
[CH3:1][O:2][C:3](=[O:10])[CH2:4][C@@H:5]([CH3:9])[C:6](O)=[O:7].C(N(CC)CC)C.C(OC(Cl)=O)C(C)C.[Cl:26][C:27]1[CH:28]=[C:29]([CH:34]=[CH:35][CH:36]=1)[C:30]([NH:32]O)=[NH:31]>C1COCC1.C(OCC)(=O)C.CN(C=O)C>[CH3:1][O:2][C:3](=[O:10])[CH2:4][C@H:5]([C:6]1[O:7][N:32]=[C:30]([C:29]2[CH:34]=[CH:35][CH:36]=[C:27]([Cl:26])[CH:28]=2)[N:31]=1)[CH3:9]

参加物

8

実験手順

To a solution of (R)-2-methylsuccinic acid 4-methyl ester (2.2 g, 15 mmol) and triethylamine (4.54 g, 45 mmol) in THF (30 ml), isobutylchloroformate (2.16 g, 15.8 mmol) was added dropwise at 0° C. After being stirred for 30 min, the 3-chloro-N-hydroxy-benzamidine (2.56 g, 15 mmol) was added. The reaction mixture was stirred at room temperature for another 30 min and then heated to 135° C. with DMF for 45 min. The reaction mixture was diluted with ethyl acetate and washed with water and brine. The organic layer was dried and concentrated to give 4.0 g (95%) of (R)-3-[3-(3-chloro-phenyl)-[1,2,4]oxadiazol-5-yl]-butyric acid methyl ester as pale-yellow oil. Step 2: (R)-3-[3-(3-Chloro-phenyl)-[1,2,4]oxadiazol-5-yl]-butyric acid hydrazide: (R)-3-[3-(3-Chloro-phenyl)-[1,2,4]oxadiazol-5-yl]-butyric acid hydrazide (430 mg, 77%) was obtained from (R)-3-[3-(3-chloro-phenyl)-[1,2,4]oxadiazol-5-yl]-butyric acid methyl ester (461.4 mg, 2.0 mmol) reacted with hydrazine hydrate (2 mL) in methanol (2 mL) at 65° C. for 1 h. 1H-NMR(CDCl3) d (ppm): 8.07 (s, 1H), 7.96 (d, 1H), 7.46 (m, 2H), 6.98 (w, 1H), 3.93 (w, 2H), 3.78 (m, 1H), 2.86 (dd, 1H), 2.55 (dd, 1H) and 1.59 (d, 3H).

後処理

  1. stirringThe reaction mixture was stirred at room temperature for another 30 min
  2. washwashed with water and brine
  3. customThe organic layer was dried
  4. concentrationconcentrated

出典と根拠

ORDレコード
ord-1c2628af7f814201bf74a2185554b12b
出典データセット
uspto-grants-2009_09
特許番号
US07585881B2

反応ノート

読み込み中…